Summary of Study ST002529

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001627. The data can be accessed directly via it's Project DOI: 10.21228/M8D434 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002529
Study TitleIn vivo 15N2-glutamine tracing by jugular vein infusion in PDAC-tumor bearing Lyz2-Arg1 and control mice
Study SummaryWe assessed the relative levels of urea cycle related metabolites in PDAC tumors in Lyz2-Cre+/+; Arg1fl/fl compared to Arg1fl/fl control host animals.
Institute
University of Chicago
Last NameApiz Saab
First NameJuan
Address929 E. 57th St.
Emailjapizsaab@uchicago.edu
Phone7738346506
Submit Date2023-03-24
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2023-04-13
Release Version1
Juan Apiz Saab Juan Apiz Saab
https://dx.doi.org/10.21228/M8D434
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Sample type Condition
SA254631A35097-120Plasma Arg1fl/fl
SA254632A35097-0Plasma Arg1fl/fl
SA254633A35096-120Plasma Arg1fl/fl
SA254634A35097-240Plasma Arg1fl/fl
SA254635A35096-240Plasma Arg1fl/fl
SA254636A35098-0Plasma Arg1fl/fl
SA254637A35098-30Plasma Arg1fl/fl
SA254638A35098-240Plasma Arg1fl/fl
SA254639A35098-120Plasma Arg1fl/fl
SA254640A35096-0Plasma Arg1fl/fl
SA254641A35097-30Plasma Arg1fl/fl
SA254642A35096-30Plasma Arg1fl/fl
SA2546430789-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546440785-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254645A35465-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546460787-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546470787-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546480787-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546490787-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254650A35465-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254651A35465-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254652A35469-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546530785-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254654A35469-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254655A35469-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254656A35465-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254657A35469-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546580788-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546590785-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254660A35066-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254661A35066-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254662A35066-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546630788-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546640789-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546650789-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254666A35089-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254667A35066-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546680788-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254669A35089-120Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546700788-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546710785-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA2546720789-0Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254673A35089-240Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254674A35089-30Plasma Lyz2-Cre+/+; Arg1fl/fl
SA254675A35098_tumor_ControlTumor Arg1fl/fl
SA254676A35097_tumor_ControlTumor Arg1fl/fl
SA254677A35096_tumor_ControlTumor Arg1fl/fl
SA254678A35466_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
SA254679A35469_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
SA254680A35465_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
SA2546810788_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
SA2546820785_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
SA2546830787_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
SA2546840789_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
SA254685A35089_tumor_Arg1_KOTumor Lyz2-Cre+/+; Arg1fl/fl
Showing results 1 to 55 of 55
  logo